Latest Breaking News On - Mansoor raza mirza - Page 1 : comparemela.com

GSK granted EC marketing authorisation for Jemperli plus chemotherapy

GSK granted EC marketing authorisation for Jemperli plus chemotherapy

Drugs, EU approves dostarlimab in first line with chemo for endometrial cancer

Dr Mirza on the Use of Dostarlimab/Chemotherapy By Molecular Class in Endometrial Cancer

Mansoor Raza Mirza, MD, discusses treatment outcomes with the use of dostarlimab plus chemotherapy in patients with primary advanced or recurrent endometrial cancer whose disease was mismatch repair deficient/microsatellite instability–high, TP53 mutated, or had no specific molecular profile.

Subgroup Analysis Shows Dostarlimab/Chemotherapy Elicits PFS Benefit in dMMR/MSI-H, TP53+, and NSMP Endometrial Cancer

Patients with primary advanced or recurrent endometrial cancer whose disease was deficient mismatch repair/microsatellite instability-high, TP53 mutated, or had no specific molecular profile, experienced a survival benefit when treated with dostarlimab-gxly plus chemotherapy vs placebo plus chemotherapy.

Biomarker testing is helping doctors find precision treatments for patients that could dramatically improve health outcomes

Innovative techniques allow clinicians to identify patients most likely to respond to treatments for hep B, respiratory diseases and cancer.